FDAnews Books Library

 

Gain Access to All Books and Reports

Our Books Library gives you year-round unrestricted access to all our books and reports.

They can be accessed, searched, downloaded and read anywhere, anytime. Topics covered include inspections, auditing, validation, recalls, pharmacovigilance, biosimilars, adverse events, QSR Data, supply chain, financial disclosure requirements and much more. You’ll automatically receive every new book we publish — we'll send you notifications to alert you of each new book in the library.  

And as an added bonus you’ll receive the most up-to-date editions of the FDA’s Code of Federal Regulations and its Investigations Operations Manual.

LOGIN

BUY NOW 1-Year Unlimited Access $997

 

Search by keyword (title of book maybe) or simply scroll through the list of titles to find what you need.

If you have any questions or are having any problems please give us a call on 703.538.7600 or email customer service.

Quality Risk Management in the EU: Concepts and Compliance

November 9, 2020
This easy-to-follow reference covers all aspects of EU quality risk management: regulatory expectations, processes, methods and tools.

Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

November 9, 2020
With this management report, you’ll discover how to move a spreadsheet toward validation, determining the best ways to conform with data integrity requirements and uncovering what FDA inspectors are looking for in a validated data analysis and reporting tool.

Data Integrity for Drug and Device Manufacturers: Avoiding Breaches and Closing Gaps

November 9, 2020
This management report is your GPS for data integrity compliance. It explains what data integrity is, how to protect it, how to spot problems and what the FDA expects.

GMP Inspection in the EU: Avoiding 12 Common Pitfalls

October 19, 2020
Good manufacturing practice (GMP) inspectors in the EU see the same noncompliance issues again and again. To successfully comply with EU GMPs, you must look beyond the surface of an issue to identify its root cause and consider how it impacts all other aspects of operation. Using case studies, this report analyzes where drugmakers went wrong and provides recommendations to avoid the same pitfalls.

Pharmaceutical Quality Risk Management: Navigating New Regulatory Requirements

October 19, 2020
The COVID-19 pandemic is making it more difficult for pharmaceutical manufacturers to maintain production levels and meet regulatory requirements. With this report you can make your quality risk management (QRM) efforts more effective. By using our expert tips, you will be able to determine which risks you need to manage, how to consistently apply risk management principles, and ways to implement a successful QRM plan.

Data Integrity in Clinical Trials: Ensuring Valid Results

October 19, 2020
Now is the time to examine your data practices and close gaps to protect the integrity and validity of your clinical trial results. This newly updated report will show you how.

Devicemaker’s Guide to EU-MDR: 71 Worksheets for Manufacturing Compliance

September 11, 2020
The EU Medical Device Regulation (EU-MDR) is complex and confusing yet you must comply by May 26, 2021.This report makes your task easier by transforming the EU-MDR’s 17 annexes into 71 section-by-section worksheets describing the requirements, listing the tasks necessary to be compliant along with providing space for you to document the steps your organization has taken.

Risk Management for Devicemakers: New Requirements in ISO 14971

September 11, 2020
You must be ready to implement the revised requirements in ISO 14971:2019 and EN ISO 14971:2019 within your risk management system by December 2022. This report provides all the details on ISO 14971:2019.

Supplier Management for Devicemakers: Qualification, Contracts and Audits

September 11, 2020
Devicemakers must choose their suppliers wisely and exercise careful oversight. This report will enable you to pick the highest-quality and most reliable firms and how to hammer out a contract that will hold the supplier to your standards.

Supplier Management for Drugmakers: Qualification, Contracts and Audits

September 11, 2020
Drugmakers must choose their suppliers wisely and exercise careful oversight. This report will enable you to pick the highest-quality and most reliable firms and how to hammer out a contract that will hold the supplier to your standards.

Company Core Data Sheets and Benefit-Risk Evaluations: A Drugmaker’s Guide to Postmarket Safety Reporting

September 11, 2020
Your company core data sheet (CCDS) must be a dynamic document, providing up-to-the-minute information on indications, pharmacology and safety. This report walks you through the CCDS and the Periodic Benefit-Risk Evaluation Report (PBRER), with a comprehensive explanation of FDA, EMA and ICH requirements for CCDS files and PBRERs.

Clinical and Performance Evaluation Under EU-MDR: New CE Mark Rules

August 5, 2020
This report outlines the new requirements and provides details on how to perform the necessary evaluations and prepare the resulting reports. It describes common pitfalls companies face in making their case to NBs and offers recommendations for sidestepping them.

Upcoming Events

Featured Products

Featured Stories

The Revised ICH E8: A Guide to New Clinical Trial Requirements

Learn More